Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome

Blood

Volumn 89, Issue 5, 1997, Pages 1690-1700

  Hoefsloot, Lies H ^b   Van Amelsvoort, Martine P ^b   Broeders, Lianne C A M ^b   Van Der Plas, Dorien C ^b   Van Lom, Kirsten ^b   Hoogerbrugge, Hans ^b   Touw, Ivo P ^b   Löwenberg, Bob ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; DIMERIZATION; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

EID: 0031035425     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1690     Document Type: Article

References (75)

1. Dunbar CE, Nienhuis AW: Myelodysplastic syndromes, in Handin RI, Stossel TP, Lux SE (eds): Blood: Principles and Practice of Hematology. Philadelphia, PA, Lippincott, 1995, p 377
2. Backx B, Breeders L, Lowenberg B: Kit ligand improves in vitro erythropoiesis in myelodysplastic syndrome. Blood 80:1213, 1992
3. Backx B, Broeders L, Touw I, Lowenberg B: Blast colony-forming cells in myelodysplastic syndrome: Decreased potential to generate erythroid precursors. Leukemia 7:75, 1993
4. Mayani H, Baines P, Bowen DT, Jacobs A: In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte-macrophage colony-stimulating factor. Leukemia 3:29, 1989
5. Merchav S, Nagler A, Fleischer-Kurtz G, Tatarsky I: Regulatory abnormalities in the marrow of patients with myelodysplastic syndromes. Br J Haematol 73:158, 1989
6. Merchav S, Wagemaker G, Souza LM, Tatarsky I: Impaired response of myelodysplastic marrow progenitors to stimulation with recombinant haemopoietic growth factors. Leukemia 5:340, 1991
7. Jacobs A, Janowska-Wieczorek A, Caro J, Bowen DT, Lewis T: Circulating erythropoietin in patients with myelodysplastic syndromes. Br J Haematol 73:36, 1989
8. Schouten HC, Vellenga E, van Rhenen DJ, de Wolf JT, Coppens PJ, Blijham GH: Recombinant human erythropoietin in patients with myelodysplastic syndromes. Leukemia 5:432, 1991
9. Hellstrom-Lindberg E: Efficacy of erythropoietin in the myelodysplastic syndromes: A meta-analysis of 205 patients from 17 studies. Br J Haematol 89:67, 1995
10. Sawada K, Krantz SB, Sawyer ST, Civin CI: Quantitation of specific binding of erythropoietin to human erythroid colony-forming cells. J Cell Physiol 137:337, 1988
11. Sawada K, Krantz SB, Dai CH, Koury ST, Horn ST, Glick AD, Civin CI: Purification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptors. J Cell Physiol 142:219, 1990
12. Wickrema A, Bondurant MC, Krantz SB: Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells. Blood 78:2269, 1991
13. Wickrema A, Krantz SB, Winkelmann JC, Bondurant MC: Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 80:1940, 1992
14. Jones SS, D'Andrea AD, Haines LL, Wong GG: Human erythropoietin receptor: Cloning, expression, and biologic characterization. Blood 76:31, 1990
15. Cosman D: The hematopoietin receptor superfamily. Cytokine 5:95, 1993
16. Nagao M, Matsumoto S, Masuda S, Sasaki R: Effect of tunicamycin treatment on ligand binding to the erythropoietin receptor: Conversion from two classes of binding sites to a single class. Blood 81:2503, 1993
17. Dong YJ, Goldwasser E: Evidence for an accessory component that increases the affinity of the erythropoietin receptor. Exp Hematol 21:483, 1993
18. Wu H, Klingmuller U, Besmer P, Lodish HF: Interaction of the erythropoietin and stem-cell-factor receptors. Nature 377:242, 1995
19. Krosl J, Damen JE, Rosten P, Krystal G, Humphries RK: The α-subunit of the interleukin-3 receptor inhibits erythropoietin-induced differentiation of Ba/F3 cells. Blood 86:253a, 1995 (abstr, suppl 1)
20. Jubinsky PT, Seiff C, Nathan DG: The β-chain of the IL-3 receptor functionally associates with the erythropoietin receptor. Blood 86:15a, 1995 (abstr, suppl 1)
21. Hermine O, Dong YJ, Goldwasser E: Effects of butyrate on the erythropoietin receptor of cell line IW201. Blood 84:811, 1994
22. Miura O, Ihle JN: Dimer- and oligomerization of the erythropoietin receptor by disulfide bond formation and significance of the region near the WSXWS motif in intracellular transport. Arch Biochem Biophys 306:200, 1993
23. Quelle DE, Quelle FW, Wojchowski DM: Mutations in the WSAWSE and cytosolic domains of the erythropoietin receptor affect signal transduction and ligand binding and internalization. Molecular and Cellular Biology 12:4553, 1992
24. Watowich SS, Hilton DJ, Lodish HF: Activation and inhibition of erythropoietin receptor function: Role of receptor dimerization. Mol Cell Biol 14:3535, 1994
25. Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN, Aoki N: Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood 84:1501, 1994
26. Witthuhn BA, Quelle FW, Silvennoinen O, Yi T, Tang B, Miura O, Ihle JN: JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 74:227, 1993
27. Tanner JW, Chen W, Young RL, Longmore GD, Shaw AS: The conserved box 1 motif of cytokine receptors is required for association with JAK kinases. J Biol Chem 270:6523, 1995
28. Quelle FW, Quelle DE, Wojchowski DM: Interleukin 3, granulocyte-macrophage colony-stimulating factor, and transfected erythropoietin receptors mediate tyrosine phosphorylation of a common cytosolic protein (pp100) in FDC-ER cells. J Biol Chem 267:17055, 1992
29. Quelle FW, Wojchowski DM: Proliferative action of erythropoietin is associated with rapid protein tyrosine phosphorylation in responsive B6SUt.EP cells. J Biol Chem 266:609, 1991
30. Gobert S, Porteu F, Pallu S, Muller O, Sabbah M, Dusanter-Fourt I, Courtois G, Lacombe C, Gisselbrecht S, Mayeux P: Tyrosine phosphorylation of the erythropoietin receptor: Role for differentiation and mitogenic signal transduction. Blood 86:598, 1995
31. Linnekin D, Evans GA, D'Andrea A, Farrar WL: Association of the erythropoietin receptor with protein tyrosine kinase activity. Proc Natl Acad Sci USA 89:6237, 1992
32. Wakao H, Harada N, Kitamura T, Mui AL, Miyajima A: Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. EMBO J 14:2527, 1995
33. Pallard C, Gouilleux F, Charon M, Groner B, Gisselbrecht S, Dusanter-Fourt I: Interleukin-3, erythropoietin, and prolactin activate a STAT5-like factor in lymphoid cells. J Biol Chem 270:15942, 1995
34. Liu X, Robinson GW, Gouilleux F, Groner B, Hennighausen L: Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci USA 92:8831, 1995
35. Mui AL-F, Wakao H, Kitamura T, Miyajima A: Dominant negative STAT5 inhibits interleukin-3 (IL-3) dependent proliferation. Blood 86:252a, 1995 (abstr, suppl 1)
36. Merchav S, Barber DL, D'Andrea AD: STAT5 antisense oligodeoxynucleotides enhance the differentiation of murine erythroleukemia cells. Blood 86:252a, 1995 (abstr, suppl 1)
37. Simon MC: Gotta have GATA. Nat Genet 11:9, 1995
38. Leonard M, Brice M, Engel JD, Papayannopoulou T: Dynamics of GATA transcription factor expression during erythroid differentiation. Blood 82:1071, 1993
39. Labbaye C, Valtieri M, Barberi T, Meccia E, Masella B, Pelosi E, Condorelli GL, Testa U, Peschle C: Differential expression and functional role of GATA-2, NF-E2, and GATA-1 in normal adult hematopoiesis. J Clin Invest 95:2346, 1995
40. Crotta S, Nicolis S, Ronchi A, Ottolenghi S, Ruzzi L, Shimada Y, Migliaccio AR, Migliaccio G: Progressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell lines. Nucleic Acids Res 18:6863, 1990
41. Dalyot N, Fibach E, Ronchi A, Rachmilewitz EA, Ottolenghi S, Oppenheim A: Erythropoietin triggers a burst of GATA-1 in normal human erythroid cells differentiating in tissue culture. Nueleic Acids Res 21:4031, 1993
42. Chiba T, Ikawa Y, Todokoro K: GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res 19:3843, 1991
43. Backx B, Broeders L, Hoefsloot LH, Wognum B, Löwenberg B: Erythropoiesis in myelodysplastic syndrome: Expression of receptors for erythropoietin and kit ligand. Leukemia 10:466, 1996
44. Nakamura Y, Komatsu N, Nakauchi H: A truncated erythropoietin receptor that fails to prevent programmed cell death of erythroid cells. Science 257:1138, 1992
45. Nakamura Y, Nakauchi H: A truncated erythropoietin receptor and cell death: A reanalysis. Science 264:588, 1994
46. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189, 1982
47. Delwel R, Touw I, Bot F, Lowenberg B: Fucose binding lectin for characterizing acute myeloid leukemia progenitor cells. Blood 68:41, 1986
48. Bot FJ, Dorssers L, Wagemaker G, Lowenberg B: Stimulating spectrum of human recombinant multi-CSF (IL-3) on human marrow precursors: Importance of accessory cells. Blood 71:1609, 1988
49. Salem M, Delwel R, Touw I, Mahmoud L, Lowenberg B: Human AML colony growth in serum-free culture. Leuk Res 12:157, 1988
50. Andrews NC, Faller DV: A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19:2499, 1991
51. Sadowski HB, Gilman MZ: Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature 362:79, 1993
52. de Koning JP, Dong F, Smith L, Schelen AM, Barge RMY, van der Plas DC, Hoefsloot LH, Löwenberg B, Touw IP: The membrane-distal cytoplasmic region of human granulocyte colony-stimulating factor receptor is required for STAT3 but not STAT1 homodimer formation. Blood 87:1335, 1996
53. Gouilleux F, Pallard C, Dusanter-Fourt I, Wakao H, Haldosen LA, Norstedt G, Levy D, Groner B: Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J 14:2005, 1995
54. Wakao H, Gouilleux F, Groner B: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO J 13:2182, 1994
55. Wagner BJ, Hayes TE, Hoban CJ, Cochran BH: The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J 9:4477, 1990
56. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow: I. Normal erythroid development. Blood 69:255, 1987
57. Miura O, Cleveland JL, Ihle JN: Inactivation of erythropoietin receptor function by point mutations in a region having homology with other cytokine receptors. Mol Cell Biol 13:1788, 1993
58. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, D'Agati V, Orkin SH, Costantini F: Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257, 1991
59. Simon MC, Pevny L, Wiles MV, Keller G, Costantini F, Orkin SH: Rescue of erythroid development in gene targeted GATA-1-mouse embryonic stem cells. Nat Genet 1:92, 1992
60. Sposi NM, Zon LI, Care A, Valtieri M, Testa U, Gabbianelli M, Mariani G, Bottero L, Mather C, Orkin SH: Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. Proc Natl Acad Sci USA 89:6353, 1992
61. Zon LI, Youssoufian H, Mather C, Lodish HF, Orkin SH: Activation of the erythropoietin receptor promoter by transcription factor GATA-1. Proc Natl Acad Sci USA 88:10638, 1991
62. Chin K, Oda N, Shen K, Noguchi CT: Regulation of transcription of the human erythropoietin receptor gene by proteins binding to GATA-1 and Sp1 motifs. Nucleic Acids Res 23:3041, 1995
63. Wu H, Liu X, Jaenisch R, Lodish HF: Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59, 1995
64. Penta K, Sawyer ST: Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STAT5 in erythroid cells. J Biol Chem 270:31282, 1995
65. Barge RMY, de Koning JP, Pouwels K, Dong F, Löwenberg B, Touw IP: Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route. Blood 87:2148, 1996
66. Damen JE, Liu L, Cutler RL, Krystal G: Erythropoietin stimulates the tyrosine phosphorylation of She and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood 82:2296; 1993
67. He TC, Jiang N, Zhuang H, Wojchowski DM: Erythropoietin-induced recruitment of She via a receptor phosphotyrosine-independent, Jak2-associated pathway. J Biol Chem 270:11055, 1995
68. Damen JE, Cutler RL, Jiao H, Yi T, Krystal G: Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J Biol Chem 270:23402, 1995
69. Damen JE, Mui AL, Puil L, Pawson T, Krystal G: Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. Blood 81:3204, 1993
70. He TC, Zhuang H, Jiang N, Waterfield MD, Wojchowski DM: Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood 82:3530, 1993
71. Miura O, Nakamura N, Ihle JN, Aoki N: Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. J Biol Chem 269:614, 1994
72. Tauchi X, Feng GS, Shen R, Hoatlin M, Bagby G Jr, Kabat D, Lu L, Broxmeyer HE: Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem 270:5631, 1995
73. Ali S, Chen Z, Lebrun J-J, Vogel W, Kharitonenkov A, Kelly PA, Ullrich A: PTP1D is a positive regulator of the prolactin signal leading to β-casein promoter activity. EMBO J 15:135, 1996
74. Klingmuller U, Lorenz U, Cantley LC, Neel BG, Lodish HF: Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 80:729, 1995
75. Hermine O, Dubart A, Porteux F, Mayeux P, Titeux M, Dumenil D, Vainchenker W: Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor. Blood 87:1746, 1996